A Study of SIPLIZUMAB in AILD and LT Patients

Clinical trial NCT06455280 · RECRUITING

Trial details

NCT number: NCT06455280
Sponsor: Elizabeth C. Verna
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Liver Disease Liver Transplant Disorder Autoimmune Hepatitis Primary Sclerosing Cholangitis End Stage Liver DIsease Cirrhosis, Liver

Start date: 2024-09-11
Primary completion: 2027-12-31
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.